Frontlight ResearchEarly access
Trial site
CHU UCL Namur / Site Sainte Elisabeth
- 8running trials
- 3closed trials
The trials here
What the 11 trials at this site are about, from their registry records.
- Conditions
- Metastatic breast cancer6 trials
- Childhood cancers1 trial
- Endometrial cancer1 trial
- Head and neck cancer1 trial
- Prostate cancer1 trial
- Triple-negative breast cancer1 trial
- Phase
- Phase 39 trials
- Phase 21 trial
- Status
- Active, not recruiting7 trials
- Completed2 trials
- Not yet recruiting1 trial
- Terminated1 trial
- Lead sponsor
- Eli Lilly and Company5 trials
- Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company1 trial
- EMD Serono Research & Development Institute, Inc.1 trial
- GBG Forschungs GmbH1 trial
- Janssen Research & Development, LLC1 trial
- and 2 more
Running trials
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Sacituzumab Govitecan in Primary HER2-negative Breast Cancer
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Metastatic breast cancer1 recruiting
Closed trials
Terminated
Completed
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026